Brooklyn, NY · Founded 2017 · Privately Held (backing)
Developer of an intranasal drug delivery platform designed to deliver medication adherence solutions for clinical trials in real-time. Validose is based in Brooklyn, NY and was founded in 2017. It was valued at $6 million at its seed round in Jan 2025, the last priced event on record. It has raised $2 million across 1 recorded round; the latest was a $1.6 million seed round in Dec 2024.
PMV mark · valuation
$6.0M
Oct 2026
Priced at
its seed round
Jan 2025
Total raised
$2.0M
Last round
Seed Round
Dec 2024
Team — not yet on record
No current team members for Validose are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Validose with a free account
·Watch Validose: the Monday email on marks, rounds and moves
